Dawson James Downgrades Kintara Therapeutics, Inc (KTRA) to Neutral

May 16, 2022 9:27 AM EDT Send to a Friend
Dawson James analyst Jason H. Kolbert downgraded Kintara Therapeutics, Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login